FindTrial
Sign In

Arteriopathy and Endothelial Function

Endothelial Dysfunction Reversibility in Patients With Peripheral Arterial Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00487617
Enrollment
50
Registered
2007-06-18
Start date
2007-07-31
Completion date
2012-04-30
Last updated
2009-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Keywords

Arteriopathy, endothelial function, fruit juice

Brief summary

To determine whether fruit juice might reverse endothelial dysfunction and whether this reversibility has a prognosis value

Interventions

PROCEDUREFruit juice or placebo absorption

absorption of 300 ml of fruit juice ; 24 hours later, absorption of 300 ml of placebo.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Peripheral arteriopathy * Stable cardio-respiratory status

Exclusion criteria

* Dialysis

Design outcomes

Primary

MeasureTime frame
Endothelial function 1 hour after taking the juice1 hour after taking the juice

Secondary

MeasureTime frame
Relationship between reversibility of the endothelial function and the patient's prognosis at 3 years3 years

Countries

France

Contacts

Primary ContactOlivier Rouyer, MD
olivier.rouyer@chru-strasbourg.fr33.3.88.11.61.22

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026